Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
As of close of business last night, Oscar Health Inc’s stock clocked out at $16.07, up 0.50% from its previous closing price of $15.99. In other words, the price has increased by $0.50 from its previous closing price. On the day, 6.26 million shares were traded.
Ratios:
To gain a deeper understanding of OSCR’s stock, we examine its different ratios. In the meantime, Its Debt-to-Equity ratio is 0.30 whereas as Long-Term Debt/Eq ratio is at 0.30.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Jefferies on December 10, 2024, initiated with a Underperform rating and assigned the stock a target price of $12.
On November 06, 2024, BofA Securities Downgraded its rating to Underperform which previously was Neutral and also lowered its target price recommendation from $21 to $13.50.
On October 07, 2024, UBS started tracking the stock assigning a Neutral rating and target price of $23.UBS initiated its Neutral rating on October 07, 2024, with a $23 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Feb 10 ’25 when STEVEN WOLIN bought 36,034 shares for $14.79 per share.
Quane Alessandrea C. sold 16,793 shares of OSCR for $271,293 on Dec 06 ’24. The EVP, Chief Insurance Officer now owns 430,216 shares after completing the transaction at $16.16 per share. On Dec 06 ’24, another insider, Blackley Richard Scott, who serves as the Chief Financial Officer of the company, sold 29,939 shares for $16.16 each. As a result, the insider received 483,668 and left with 914,402 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 0.43 while its Price-to-Book (P/B) ratio in mrq is 3.97.
Stock Price History:
Over the past 52 weeks, OSCR has reached a high of $23.79, while it has fallen to a 52-week low of $12.43. The 50-Day Moving Average of the stock is 8.07%, while the 200-Day Moving Average is calculated to be -7.26%.
Shares Statistics:
A total of 214.97M shares are outstanding, with a floating share count of 173.79M. Insiders hold about 29.72% of the company’s shares, while institutions hold 66.21% stake in the company.
Earnings Estimates
At present, 2.0 analysts are actively evaluating the performance of Oscar Health Inc (OSCR) in the stock market.The consensus estimate for the next quarter is $0.41, with high estimates of $0.44 and low estimates of $0.37.
Analysts are recommending an EPS of between $0.88 and $0.61 for the fiscal current year, implying an average EPS of $0.76. EPS for the following year is $1.18, with 5.0 analysts recommending between $1.85 and $0.75.
Revenue Estimates
In the current quarter, 4 analysts expect revenue to total $2.84B. It ranges from a high estimate of $2.94B to a low estimate of $2.77B. As of the current estimate, Oscar Health Inc’s year-ago sales were $2.14BFor the next quarter, 4 analysts are estimating revenue of $2.77B. There is a high estimate of $2.83B for the next quarter, whereas the lowest estimate is $2.63B.
A total of 6 analysts have provided revenue estimates for OSCR’s current fiscal year. The highest revenue estimate was $12.69B, while the lowest revenue estimate was $10.59B, resulting in an average revenue estimate of $11.36B. In the same quarter a year ago, actual revenue was $9.18BBased on 6 analysts’ estimates, the company’s revenue will be $11.67B in the next fiscal year. The high estimate is $13.83B and the low estimate is $10.01B.
